Yang et al. have indicated that BNIP3L/NIX may be a potential therapeutic target for ischaemic stroke, and BNIP3L/NIX may be in the mitochondria induced by cerebral ischaemia‐reperfusion (I‐R). Here, BNIP3L is linked to ischemia.